Annual Working Capital
$453.17 M
+$88.91 M+24.41%
December 31, 2023
Summary
- As of February 12, 2025, NMRA annual working capital is $453.17 million, with the most recent change of +$88.91 million (+24.41%) on December 31, 2023.
- During the last 3 years, NMRA annual working capital has risen by +$268.70 million (+145.66%).
- NMRA annual working capital is now at all-time high.
Performance
NMRA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$316.87 M
-$58.33 M-15.55%
September 30, 2024
Summary
- As of February 12, 2025, NMRA quarterly working capital is $316.87 million, with the most recent change of -$58.33 million (-15.55%) on September 30, 2024.
- Over the past year, NMRA quarterly working capital has dropped by -$101.31 million (-24.23%).
- NMRA quarterly working capital is now -36.19% below its all-time high of $496.61 million, reached on September 30, 2023.
Performance
NMRA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
NMRA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.4% | -24.2% |
| 3 y3 years | +145.7% | -0.2% |
| 5 y5 years | +10000.0% | -0.2% |
NMRA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +24.4% | -36.2% | +2.0% |
| 5 y | 5-year | at high | >+9999.0% | -36.2% | +71.8% |
| alltime | all time | at high | >+9999.0% | -36.2% | +71.8% |
Neumora Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $316.87 M(-15.5%) |
| Jun 2024 | - | $375.19 M(-10.3%) |
| Mar 2024 | - | $418.18 M(-7.7%) |
| Dec 2023 | $453.17 M(+24.4%) | $453.17 M(-8.7%) |
| Sep 2023 | - | $496.61 M(+59.9%) |
| Jun 2023 | - | $310.52 M(-14.8%) |
| Dec 2022 | $364.26 M | $364.26 M(+14.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $317.53 M(-8.0%) |
| Mar 2022 | - | $345.00 M(-12.1%) |
| Dec 2021 | $392.32 M(+112.7%) | - |
| Dec 2021 | - | $392.32 M(-7.1%) |
| Sep 2021 | - | $422.13 M(+128.8%) |
| Dec 2020 | $184.47 M(<-9900.0%) | $184.47 M |
| Dec 2019 | -$21.00 K | - |
FAQ
- What is Neumora Therapeutics annual working capital?
- What is the all time high annual working capital for Neumora Therapeutics?
- What is Neumora Therapeutics annual working capital year-on-year change?
- What is Neumora Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Neumora Therapeutics?
- What is Neumora Therapeutics quarterly working capital year-on-year change?
What is Neumora Therapeutics annual working capital?
The current annual working capital of NMRA is $453.17 M
What is the all time high annual working capital for Neumora Therapeutics?
Neumora Therapeutics all-time high annual working capital is $453.17 M
What is Neumora Therapeutics annual working capital year-on-year change?
Over the past year, NMRA annual working capital has changed by +$88.91 M (+24.41%)
What is Neumora Therapeutics quarterly working capital?
The current quarterly working capital of NMRA is $316.87 M
What is the all time high quarterly working capital for Neumora Therapeutics?
Neumora Therapeutics all-time high quarterly working capital is $496.61 M
What is Neumora Therapeutics quarterly working capital year-on-year change?
Over the past year, NMRA quarterly working capital has changed by -$101.31 M (-24.23%)